Quick Takeaways
- BML Investment Partners, L.P. filed SCHEDULE 13D for Elevation Oncology, Inc. Common stock, par value $0.0001 per share (ELEV).
- Disclosed ownership: 9.9%.
- Date of event: 16 Apr 2025.
BML Investment Partners, L.P. - 16 Apr 2025 SCHEDULE 13D Report for Elevation Oncology, Inc. Common stock, par value $0.0001 per share (ELEV)
- Filing Manager
- BML Investment Partners, L.P.
- Reporting Manager
- BML Investment Partners, L.P.
- Symbol
- ELEV
- Shares outstanding
- 59,504,384 shares
- Disclosed Ownership
- 5,890,934 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13D
- Filing time
- 16 Apr 2025, 09:16:44 UTC
- Date of event
- 16 Apr 2025
- Previous filing
- 26 Mar 2025
- Next filing
- 28 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BML Investment Partners, L.P. disclosed 9.9% ownership in Elevation Oncology, Inc. Common stock, par value $0.0001 per share (ELEV) on 16 Apr 2025."
What Changed
- Previous schedule filing date: 26 Mar 2025.
- Current filing was accepted on 16 Apr 2025, 09:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 9.9% | 5,890,934 | 0 | 5,890,934 | Braden M Leonard | Braden M Leonard - Managing Member of BML Capital Management, LLC | 0001373604 |